Vol. 7, Issue 9 (2018)

Author(s):
Sri Krishna Chaitanya J, Pramoth Narashimman V, Karuna J and Gyana Prasuna R

Abstract:
In general, environment of the pharmaceutical company consists of water, air and surfaces, which are often contaminated with microorganisms introduced from humans and environment. These germs represent microbial reservoirs that may pose a risk of product contamination. In the current study, we determined the microbiological quality of the surfaces in a selected inanimate surfaces in a pharmaceutical parenteral (sterile injections) manufacturing company, Chennai, in order to prevent microbial contaminations. A total of 231 samples were collected in the study over a period of one year. The samples were collected from seven different surfaces. An overall microbial identification showed the presence of 11 species which were alienated into gram positive (6 species) or gram negative (2 species) bacteria, fungi (2 species) and yeast (1 species) respectively. The current study results confirmed the need to implement systematic measures in pharmaceutical company surveillance to be adapted as a comprehensive policy for the prevention of microbial contaminations including a systematic surface treatment protocol